Monday, 28 Sep 2020

Industry

With the second largest biotechnology market in the world, it’s no wonder that companies are turning to Japan in search of untapped opportunities. The Japanese biotechnology sector is expected to grow from about $12 billion in 2002 to $16 billion in 2005. Japan has the second largest pharmaceutical market in the world. Deregulation in Japan has led to the growth of more than 400 bioventures. In addition, Japanese venture capital is highly active in biotechnology, and the VC pool available is at an all time high.

Reports
Market Reports on the Bio-Related Industry in Japan

Regulations
Laws Related to the Biotechnology Industry

Clusters
Overview of Biotechnology Clusters in Japan

Case Studies
Biotech-Related Companies doing business with Japan